Clinical trial
Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration…
NCT00411268 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00411268 |
|---|---|
| Title | Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain |
| Official title | Safety, Efficacy and Impact on Quality of Life of Long-Term Administration of Dilaudid CR (Hydromorphone HCI) in Patients With Chronic Low Back Pain |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Low Back Pain |
| Intervention type | Drug |
| Interventions | OROS hydromorphone HCI SR (slow release) |
| Enrollment | 207 |
| Completion | Jun 1, 2001 |
| First posted | Dec 13, 2006 |
| Last update posted | Apr 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: